198 related articles for article (PubMed ID: 12942462)
21. Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Kiuchi T; Tanaka K; Inomata Y; Uemoto S; Satomura K; Egawa H; Uyama S; Sano K; Okajima H; Yamaoka Y
Transplant Proc; 1996 Dec; 28(6):3171-2. PubMed ID: 8962229
[No Abstract] [Full Text] [Related]
22. Generic tacrolimus (Pan Graf) in renal transplantation: an experience of 155 recipients in India.
Guleria S; Kamboj M; Chatterjee A; Sharma M; Awasthy V; Dinda A; Mahajan S; Bhowmik D; Gupta S; Agarwal SK; Tiwari SC
Transplant Proc; 2008 Sep; 40(7):2237-9. PubMed ID: 18790202
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
24. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of neurologic complications by brain MRI in kidney and liver transplant recipients.
Agildere AM; Başaran C; Cakir B; Ozgül E; Kural F; Haberal M
Transplant Proc; 2006 Mar; 38(2):611-8. PubMed ID: 16549189
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus after living donor liver transplantation: data from mainland China.
Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
[TBL] [Abstract][Full Text] [Related]
27. FK506-induced fulminant leukoencephalopathy after single-lung transplantation.
Thyagarajan GK; Cobanoglu A; Johnston W
Ann Thorac Surg; 1997 Nov; 64(5):1461-4. PubMed ID: 9386723
[TBL] [Abstract][Full Text] [Related]
28. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
Forgacs B; Merhav HJ; Lappin J; Mieles L
Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience.
Emiroglu R; Ayvaz I; Moray G; Karakayali H; Haberal M
Transplant Proc; 2006 Mar; 38(2):619-21. PubMed ID: 16549190
[TBL] [Abstract][Full Text] [Related]
30. [Reversible posterior leukoencephalopathy syndrome in patients with immunosuppressive treatment: report of four cases].
Hernández Ch M; Núñez F A; Mesa L T; Escobar H R; Barriga C F; Huete L I
Rev Med Chil; 2008 Jan; 136(1):93-8. PubMed ID: 18483659
[TBL] [Abstract][Full Text] [Related]
31. Akinetic mutism induced by tacrolimus.
Sierra-Hidalgo F; Martínez-Salio A; Moreno-García S; de Pablo-Fernández E; Correas-Callero E; Ruiz-Morales J
Clin Neuropharmacol; 2009; 32(5):293-4. PubMed ID: 19820432
[TBL] [Abstract][Full Text] [Related]
32. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients.
Karasu Z; Gurakar A; Carlson J; Pennington S; Kerwin B; Wright H; Nour B; Sebastian A
J Okla State Med Assoc; 2001 Apr; 94(4):121-3. PubMed ID: 11392178
[TBL] [Abstract][Full Text] [Related]
33. Fatty liver due to high levels of serum tacrolimus after liver transplantation.
Tümgör G; Ankan C; Nart D; Kihiç M; Aydoğdu S
Turk J Pediatr; 2007; 49(2):223-5. PubMed ID: 17907528
[TBL] [Abstract][Full Text] [Related]
34. A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small-for-size grafts.
Kishino S; Ohno K; Shimamura T; Furukawa H; Todo S
Clin Transplant; 2006; 20(4):443-9. PubMed ID: 16842519
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus-related seizure in the early postoperative period after liver transplantation.
Sevmis S; Karakayali H; Emiroglu R; Akkoc H; Haberal M
Transplant Proc; 2007 May; 39(4):1211-3. PubMed ID: 17524935
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
[TBL] [Abstract][Full Text] [Related]
37. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P
Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
[TBL] [Abstract][Full Text] [Related]
38. FK506 may reduce early liver injury following living related liver transplantation.
Kato T; Sato Y; Kurosaki I; Yamamoto S; Hirano K; Nakatsuka H; Kobayashi T; Kameyama H; Watanabe T; Shirai Y; Hatakeyama K
Hepatogastroenterology; 2006; 53(70):580-3. PubMed ID: 16995466
[TBL] [Abstract][Full Text] [Related]
39. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient.
Hernández G; Jiménez C; Arriba L; Moreno E; Lucas M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):526-31. PubMed ID: 11709689
[TBL] [Abstract][Full Text] [Related]
40. [Progressive multifocal leukoencephalopathy in a female patient after kidney transplantation].
Táborský P; Hrabánek J; Jirásek A; Matl I
Vnitr Lek; 1998 Feb; 44(2):108-10. PubMed ID: 9820086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
